Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of PepGen (NASDAQ:PEPG) through any online brokerage.
Other companies in PepGen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
PepGen has a consensus price target of $10.00.
The stock price for PepGen (NASDAQ: PEPG) is $2.34 last updated October 5, 2026 at 9:37 AM EDT.
There are no upcoming dividends for PepGen.
PepGen does not have any upcoming earnings scheduled.
There is no upcoming split for PepGen.
PepGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.